Butyrate increases the formation of anti-angiogenic vascular endothelial growth factor variants in human lung microvascular endothelial cells

Molecular Biology Reports

Volumn 37, Issue 8, 2010, Pages 3729-3734

  Ciura, J ^a   Jagodzinski P P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Angiogenesis; Epigenetic regulation; Vascular endothelial growth factor

Indexed keywords

BUTYRIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121A; VASCULOTROPIN 121B; VASCULOTROPIN 165A; VASCULOTROPIN 165B; VASCULOTROPIN 189A; VASCULOTROPIN 189B;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LUNG BLOOD VESSEL; PROTEIN ISOLATION; PROTEIN VARIANT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR GROWTH; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANGIOGENESIS INHIBITORS; BUTYRATES; CELL LINE; ENDOTHELIAL CELLS; HUMANS; LUNG; MICROVESSELS; PROTEIN ISOFORMS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78149465202     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0026-1     Document Type: Article

References (52)

1. S Osinsky M Zavelevich P Vaupel 2009 Tumor hypoxia and malignant progression Exp Oncol 31 80 86 1:CAS:528:DC%2BD1MXhtVWitrjN 19550396
2. J Folkman 2003 Angiogenesis and apoptosis Semin Cancer Biol 13 159 167 1:CAS:528:DC%2BD3sXitlWnsLg%3D 10.1016/S1044-579X(02)00133-5 12654259 (Pubitemid 36315933)
3. E Miller-Kasprzak PP Jagodziński 2007 Endothelial progenitor cells as a new agent contributing to vascular repair Arch Immunol Ther Exp 55 247 259 1:CAS:528:DC%2BD2sXhtFWqt7vL 10.1007/s00005-007-0027-5 (Pubitemid 47262710)
4. H Rumpold D Wolf R Koeck, et al. 2004 Endothelial progenitor cells: a source for therapeutic vasculogenesis? J Cell Mol Med 8 509 518 10.1111/j.1582-4934.2004.tb00475.x 15601579
5. Zhang C, Zhang X, Liu C et al (2009) Expression of endostatin mediated by a novel non-viral delivery system inhibits human umbilical vein endothelial cells in vitro. Mol Biol Rep doi: 10.1007/s11033-009-9600-9
6. N Chung BK Jee SW Chae, et al. 2009 HOX gene analysis of endothelial cell differentiation in human bone marrow-derived mesenchymal stem cells Mol Biol Rep 36 227 235 1:CAS:528:DC%2BD1cXhsFCmsLbJ 10.1007/s11033-007-9171-6 17972163
7. Tang J, Wang J, Song H et al (2009) Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions. Mol Biol Rep. doi: 10.1007/s11033-009-9642-z
8. X Bai Z Liang S Zhao, et al. 2009 The porcine ANG, RNASE1 and RNASE6 genes: molecular cloning, polymorphism detection and the association with haematological parameters Mol Biol Rep 36 2405 2411 1:CAS:528:DC%2BD1MXht1yrs7rN 10.1007/s11033-009-9471-0 19247805
9. AM Byrne DJ Bouchier-Hayes JH Harmey 2005 Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF) J Cell Mol Med 9 777 794 1:CAS:528:DC%2BD2sXlvFKhtLg%3D 10.1111/j.1582-4934.2005.tb00379.x 16364190
10. DJ Hicklin LM Ellis 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 1011 1027 1:CAS:528:DC%2BD2MXit1Gnsro%3D 10.1200/JCO.2005.06.081 15585754 (Pubitemid 46202320)
11. IH Onen E Konac M Eroglu, et al. 2008 No association between polymorphism in the vascular endothelial growth factor gene at position-460 and sporadic prostate cancer in the Turkish population Mol Biol Rep 35 17 22 1:CAS:528:DC%2BD1cXhtFahur4%3D 10.1007/s11033-006-9046-2 17216542
12. T Wang K Hu J Ren, et al. 2010 Polymorphism of VEGF-2578C/A associated with the risk and aggressiveness of nasopharyngeal carcinoma in a Chinese population Mol Biol Rep 37 59 65 1:CAS:528:DC%2BC3cXisFSmtg%3D%3D 10.1007/s11033-009-9526-2 19340604
13. DO Bates TG Cui JM Doughty, et al. 2002 VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma Cancer Res 62 4123 4131 1:CAS:528:DC%2BD38XlsV2ltrw%3D 12124351
14. J Woolard WY Wang HS Bevan, et al. 2004 VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression Cancer Res 64 7822 7835 1:CAS:528:DC%2BD2cXptFemu7k%3D 10.1158/0008-5472.CAN-04-0934 15520188 (Pubitemid 39446915)
15. E Miller-Kasprzak PP Jagodziński 2008 5-Aza-2′-deoxycytidine increases the expression of anti-angiogenic vascular endothelial growth factor 189b variant in human lung microvascular endothelial cells Biomed Pharmacother 62 158 163 1:CAS:528:DC%2BD1cXjs1Wgs7w%3D 10.1016/j.biopha.2007.07.015 17851027 (Pubitemid 351381933)
16. ES Rennel AH Varey AJ Churchill, et al. 2009 VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo Br J Cancer 101 1183 1193 1:CAS:528:DC%2BD1MXhtF2lu7rE 10.1038/sj.bjc.6605249 19707198
17. Y Qiu C Hoareau-Aveilla S Oltean, et al. 2009 The anti-angiogenic isoforms of VEGF in health and disease Biochem Soc Trans 37 1207 1213 1:CAS:528:DC%2BD1MXhsVersr%2FI 10.1042/BST0371207 19909248
18. S Thiagalingam KH Cheng HJ Lee, et al. 2003 Histone deacetylases: unique players in shaping the epigenetic histone code Ann N Y Acad Sci 983 84 100 1:CAS:528:DC%2BD3sXjt1yrs7g%3D 10.1111/j.1749-6632.2003.tb05964.x 12724214
19. MW Luczak PP Jagodzinski, et al. 2006 The role of DNA methylation in cancer development Folia Histochem Cytobiol 44 143 154 1:CAS:528: DC%2BD28XhtFChsrvP 16977793
20. B Pajak A Orzechowski B Gajkowska 2007 Molecular basis of sodium butyrate-dependent proapoptotic activity in cancer cells Adv Med Sci 52 83 88 1:CAS:528:DC%2BD1cXks12lsQ%3D%3D 18217395
21. JG Chang HM Hsieh-Li YJ Jong, et al. 2001 Treatment of spinal muscular atrophy by sodium butyrate Proc Natl Acad Sci USA 98 9808 9813 1:CAS:528:DC%2BD3MXmtlCms7c%3D 10.1073/pnas.171105098 11504946 (Pubitemid 32769385)
22. L Brichta Y Hofmann E Hahnen, et al. 2003 Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy Hum Mol Genet 12 2481 2489 1:CAS:528:DC%2BD3sXnsVekt70%3D 10.1093/hmg/ddg256 12915451 (Pubitemid 37220412)
23. M Nissim-Rafinia M Aviram SH Randell, et al. 2004 Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation EMBO Rep 5 1071 1077 1:CAS:528:DC%2BD2cXptFemsrg%3D 10.1038/sj.embor.7400273 15472711 (Pubitemid 39600206)
24. H Piotrowska PP Jagodzinski 2007 Trichostatin A, sodium butyrate, and 5-aza-2′-deoxycytidine alter the expression of glucocorticoid receptor alpha and beta isoforms in Hut-78 T- and Raji B-lymphoma cell lines Biomed Pharmacother 61 451 454 1:CAS:528:DC%2BD2sXpt1Crtr8%3D 10.1016/j.biopha.2007.03. 007 17498915 (Pubitemid 47239342)
25. H Piotrowska PP Jagodzinski 2009 Glucocorticoid receptor alpha and beta variant expression is associated with ASF/SF2 splicing factor upregulation in HT-29 colon cancer and MCF-7 breast carcinoma cells Arch Med Res 40 156 162 1:CAS:528:DC%2BD1MXls1GksL0%3D 10.1016/j.arcmed.2009.02.004 19427965
26. RM Perrin O Konopatskaya Y Qiu, et al. 2005 Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor Diabetologia 48 2422 2447 1:CAS:528:DC%2BD2MXht1Skt7vM 10.1007/s00125-005-1951-8 16193288 (Pubitemid 41618935)
27. C Kieda M Paprocka A Krawczenko, et al. 2002 New human microvascular endothelial cell lines with specific adhesion molecules phenotypes Endothelium 9 247 261 1:CAS:528:DC%2BD38XovVCksb0%3D 10.1080/10623320214736 12572856 (Pubitemid 36040397)
28. P Chomczynski N Sacchi 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 156 159 1:CAS:528:DyaL2sXitFSns7Y%3D 10.1016/0003-2697(87)90021-2 2440339
29. A Szabo CM Perou M Karaca 2004 Statistical modeling for selecting housekeeper genes Genome Biol 5 R59 10.1186/gb-2004-5-8-r59 15287981
30. S Debicki PP Jagodzinski 2009 Apicidin decreases phospholipase C gamma-1 transcript and protein in Hut-78 T lymphoma cells Biomed Pharmacother 63 543 547 1:CAS:528:DC%2BD1MXpsFylsb0%3D 10.1016/j.biopha.2008.09.008 18993024
31. R Díaz C Peña J Silva, et al. 2008 p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis Int J Cancer 123 1060 1067 10.1002/ijc.23619 18546269
32. RO Pritchard-Jones DB Dunn Y Qiu, et al. 2007 Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma Br J Cancer 97 223 230 1:CAS:528:DC%2BD2sXnsFaqsLk%3D 10.1038/sj.bjc.6603839 17595666 (Pubitemid 47057469)
33. ES Rennel MA Hamdollah-Zadeh ER Wheatley, et al. 2008 Recombinant human VEGF165b protein is an effective anti-cancer agent in mice Eur J Cancer 44 1883 1894 1:CAS:528:DC%2BD1cXhtVamt7rF 10.1016/j.ejca.2008.05.027 18657413
34. E Rennel E Waine H Guan, et al. 2008 The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice Br J Cancer 98 1250 1257 1:CAS:528:DC%2BD1cXktVKhsLk%3D 10.1038/sj.bjc.6604309 18349828 (Pubitemid 351481687)
35. M Nishi Y Abe Y Tomii, et al. 2005 Cell binding isoforms of vascular endothelial growth factor-A (VEGF189) contribute to blood flow-distant metastasis of pulmonary adenocarcinoma Int J Oncol 26 1517 1524 1:CAS:528:DC%2BD2MXkvFyrtLs%3D 15870864
36. D Scharlau A Borowicki N Habermann, et al. 2009 Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre Mutat Res 682 39 53 1:CAS:528:DC%2BD1MXhtVenu7vL 10.1016/j.mrrev.2009.04.001 19383551
37. 2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors J Med Chem 47 467 474 1:CAS:528:DC%2BD3sXps1GmtLs%3D 10.1021/jm0303655 14711316 (Pubitemid 38057888)
38. A Gozzini E Rovida P Dello Sbarba, et al. 2003 Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts Cancer Res 63 8955 8961 1:CAS:528:DC%2BD3sXhtVSqtbnP 14695213
39. D Blank-Porat T Gruss-Fischer N Tarasenko, et al. 2007 The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties Cancer Lett 256 39 48 1:CAS:528:DC%2BD2sXpvFGrtb0%3D 10.1016/j.canlet.2007.05.011 17611019 (Pubitemid 47333328)
40. M Louis RR Rosato L Brault, et al. 2004 The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress Int J Oncol 25 1701 1711 1:CAS:528:DC%2BD2MXhsVOqsQ%3D%3D 15547708
41. Y Terao J Nishida S Horiuchi, et al. 2001 Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells Int J Cancer 94 257 267 1:CAS:528:DC%2BD3MXntVGksrk%3D 10.1002/ijc.1448 11668507 (Pubitemid 32911422)
42. MJ Roy S Dionne G Marx, et al. 2009 In vitro studies on the inhibition of colon cancer by butyrate and carnitine Nutrition 25 1193 1201 1:CAS:528:DC%2BD1MXht1GgtrbL 10.1016/j.nut.2009.04.008 19619983
43. JK Park CH Cho S Ramachandran, et al. 2006 Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3-kinase inhibition in the human cervical cancer cell-line Cancer Res Treat 38 112 117 10.4143/crt.2006.38. 2.112 19771269
44. J Sonnemann M Hartwig A Plath, et al. 2006 Histone deacetylase inhibitors require caspase activity to induce apoptosis in lung and prostate carcinoma cells Cancer Lett 232 148 160 1:CAS:528:DC%2BD28XhtFWhurY%3D 10.1016/j.canlet.2005.02.009 16458111 (Pubitemid 43170964)
45. YH Choi 2006 Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity Int J Oncol 29 1207 1312 1:CAS:528:DC%2BD28Xht1Wjs7vF 17016653
46. L Xi G Chen J Zhou, et al. 2006 Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway Apoptosis 11 789 798 1:CAS:528:DC%2BD28XlsV2ksLc%3D 10.1007/s10495-006-5701-2 16554963 (Pubitemid 43876848)
47. D Zgouras A Wächtershäuser D Frings, et al. 2003 Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1alpha nuclear translocation Biochem Biophys Res Commun 300 832 838 1:CAS:528:DC%2BD3sXmsVCgsQ%3D%3D 10.1016/S0006-291X(02)02916-9 12559948
48. SH Kim KW Kim JW Jeong 2007 Inhibition of hypoxia-induced angiogenesis by sodium butyrate, a histone deacetylase inhibitor, through hypoxia-inducible factor-1alpha suppression Oncol Rep 17 793 797 17342317
49. H Ogawa P Rafiee PJ Fisher, et al. 2003 Sodium butyrate inhibits angiogenesis of human intestinal microvascular endothelial cells through COX-2 inhibition FEBS Lett 554 88 94 1:CAS:528:DC%2BD3sXosVymu7g%3D 10.1016/S0014-5793(03)01110-4 14596920 (Pubitemid 37324820)
50. N Tarasenko A Nudelman I Tarasenko, et al. 2008 Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex) Clin Exp Metastasis 25 703 716 1:CAS:528:DC%2BD1cXhtlClur3M 10.1007/s10585-008-9179-x 18506586
51. C Pellizzaro D Coradini MG Daidone 2002 Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29 Carcinogenesis 23 735 740 1:CAS:528:DC%2BD38XktFyqs7c%3D 10.1093/carcin/23.5.735 12016145
52. DL Black 2003 Mechanisms of alternative pre-messenger RNA splicing Annu Rev Biochem 72 291 336 1:CAS:528:DC%2BD3sXntFSgtLg%3D 10.1146/annurev.biochem. 72.121801.161720 12626338 (Pubitemid 36930448)